- Home
- RNA vs DCI Comparison
RNA vs DCI Comparison
Compare RNA & DCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNA | DCI |
|---|---|---|
| Founded | 2012 | 1915 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Pollution Control Equipment |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 11.7B |
| IPO Year | 2020 | 1987 |
Fundamental Metrics
Financial Performance| Metric | RNA | DCI |
|---|---|---|
| Price | $72.61 | $101.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 5 |
| Target Price | $69.26 | ★ $98.00 |
| AVG Volume (30 Days) | ★ 1.7M | 610.5K |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 1.16% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.21 |
| Revenue | $20,868,000.00 | ★ $3,726,200,000.00 |
| Revenue This Year | $88.12 | $4.69 |
| Revenue Next Year | $18.11 | $4.71 |
| P/E Ratio | ★ N/A | $32.22 |
| Revenue Growth | ★ 106.27 | 2.37 |
| 52 Week Low | $21.51 | $57.45 |
| 52 Week High | $72.74 | $103.78 |
Technical Indicators
Market Signals| Indicator | RNA | DCI |
|---|---|---|
| Relative Strength Index (RSI) | 65.35 | 65.56 |
| Support Level | $72.40 | $99.96 |
| Resistance Level | $72.66 | $103.32 |
| Average True Range (ATR) | 0.17 | 1.88 |
| MACD | -0.10 | 0.15 |
| Stochastic Oscillator | 71.57 | 80.86 |
Price Performance
Historical ComparisonAbout RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About DCI Donaldson Company Inc.
Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.7 billion in revenue in its fiscal 2025.